Product Images Seasonique

This is a collection of studies on the use of Combined Oral Contraceptives (COC) and its effects on women's health. The studies are conducted in different countries including the US, France, Denmark, and the UK. The studies compare the health risks between women who have ever used COC and those who have never used it, as well as comparing the risks between current COC users and never-users. The results are presented in different formats including odds ratio, relative risk and hazard ratio. The provided table shows the Effect Estimate of the studies.*

This text provides information about different forms of birth control methods and the range of pregnancy rates associated with them. It mentions implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal rings with hormones, condoms, diaphragm, spermicide, withdrawal method, and the option of no birth control. It highlights the pregnancy rate differences among these methods, with fewer than 1 pregnancy per 100 women per year for highly effective methods such as implants, injections, and sterilization, while no birth control can lead to 85 or more pregnancies per 100 women in one year. The text also suggests natural family planning methods, such as avoiding sex during the most fertile days of the monthly cycle.*

This appears to be a schedule or calendar for a medication called "Seasonique" with different dosage instructions depending on the day and week. However, the text is not entirely readable due to errors.*

This is a description of two extended-cycle tablet dispensers, each containing 91 tablets (NG 51285-087-87 and NDG 51285-087-87) of Seasonique (levonorgestrel/ethinyl estradiol). The product is intended to prevent pregnancy and does not protect against sexually transmitted diseases. This product is distributed by Teva Pharmaceuticals USA. The text also includes a "Serialization Coding Area" and a numerical code (3010103902), but their purpose is not mentioned.*